bn:26187391n
Noun Concept
AR
No term available
EN
Brexucabtagene autoleucel, sold under the brand name Tecartus, is a cell-based gene therapy medication for the treatment of mantle cell lymphoma and acute lymphoblastic leukemia. Wikipedia
Relations
Sources